GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (BOM:544172) » Definitions » Total Receivables

Indegene (BOM:544172) Total Receivables : ₹7,514 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Indegene Total Receivables?

Indegene's Total Receivables for the quarter that ended in Mar. 2025 was ₹7,514 Mil.


Indegene Total Receivables Historical Data

The historical data trend for Indegene's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene Total Receivables Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Receivables
2,854.39 4,449.48 6,562.66 6,480.00 7,514.00

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 6,480.00 - 7,188.00 - 7,514.00

Indegene Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Indegene Total Receivables Related Terms

Thank you for viewing the detailed overview of Indegene's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Indegene Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines